Immunoassay of Estradiol: Unanticipated Suppression by Unconjugated Estriol

Clinical Chemistry

Volumn 50, Issue 1, 2004, Pages 160-165

  Cao, Zhimin ^a   Swift, Thomas A ^b   West, Clint A ^a   Rosano, Thomas G ^b   Rej, Robert ^a,c  

^a WADSWORTH CENTER   (United States)

^b ALBANY MEDICAL CENTER   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRIOL; HYDROCORTISONE; PROGESTERONE; TESTOSTERONE;

ACCURACY; ARTICLE; BLOOD SAMPLING; CLINICAL LABORATORY; CONJUGATION; CONTROLLED STUDY; ESTRIOL BLOOD LEVEL; ESTROGEN ACTIVITY; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; REPRODUCIBILITY;

BLOOD SPECIMEN COLLECTION; ESTRADIOL; ESTRIOL; HUMANS; IMMUNOASSAY; MALE; QUALITY CONTROL;

EID: 1642492774     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.023325     Document Type: Article

References (32)

1. Evers JL, Slaats P, Land JA, Dumoulin JC, Dunselman GA. Elevated levels of basal estradiol-17β predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Fertil Steril 1998;69:1010-4.
2. Mikkelsen AL, Andersson AM, Skakkebaek NE, Lindenberg S. Basal concentrations of oestradiol may predict the outcome of in-vitro maturation in regularly menstruating women. Hum Reprod 2001;16:862-7.
3. Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome In patients undergoing in vitro fertilization. Fertil Steril 1995;64:991-4.
4. Phelps JY, Levine AS, Hickman TN, Zacur HA, Wallach EE, Hinton EL. Day 4 estradiol levels predict pregnancy success in women undergoing controlled ovarian hyperstimulation for IVF. Fertil Steril 1998;69:1015-9.
5. Ross JW, Fraser MD, Moore TD. Analytic clinical laboratory precision-state of the art for thirty-one analysis. Am J Clin Pathol 1980;74(4 Suppl):521-30.
6. World Health Organization. WHO Consultation on International Biological Standards for In Vitro Diagnostic Procedures, September 14-15, 2000, Geneva, Switzerland, http://www.who.int/biologicals/Meeting-Reports/Doc/BIVDOOSep14.pdf (Accessed May 2003).
7. Taieb J, Benattar C, Birr AS, Lindenbaum A. Limitations of steroid determination by direct immunoassay. Clin Chem 2002;48:583-5.
8. Middle J. Standardization of steroid hormone assays. Ann Clin Biochem 1998;35:354-63.
9. Diver MJ, Nisbet JA. Warning on plasma oestradiol measurement. Lancet 1987;2:1097.
10. Sinicco A, Raiteri R, Rossati A, Savarino A, Perri GD. Efavirenz interference in estradiol ELISA assay. Clin Chem 2000;46:734-5.
11. Mikkelsen AL, Borggaard B, Lebech PE. Results of serial measurement of estradiol in serum with six different methods during ovarian stimulation. Gynecol Obstet Invest 1996;41:35-40.
12. Valdes R Jr, Jortani S. Unexpected suppression of immunoassay results by cross-reactivity: now a demonstrated cause for concern. Clin Chem 2002;48:405-6.
13. Carr B. Disorders of the ovaries and female reproductive tract. In: Wilson JD, Foster DW, Kronenberg HM, Larse PR, et al. eds. Williams textbook of endocrinology, 9th ed. Philadelphia: WB Saunders, 1998: 751-817.
14. Kim JB, Barnard GJ, Collins WP, Kohen F, Lindner HR, Eshhar Z. Measurement of plasma estradiol-17β by solid-phase chemiluminescence immunoassay. Clin Chem 1982;28:1120-4.
15. Wright JV, Schliesman B, Robinson L. Comparative measurements of serum estriol, estradiol, and estrone in non-pregnant, premenopausal women; a preliminary investigation. Altern Med Rev 1999;4:266-70.
16. Steimer W, Muller C, Eber B, Emmanuilidis K. Intoxication due to negative canrenone interference in digoxin drug monitoring. Lancet 1999;354:1176-7.
17. Steimer W, Müller C, Eber B. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids. Clin Chem 2002;48:507-16.
18. Dasgupta A, Trejo O. Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations. Am J Clin Pathol 1999;111:406-10.
19. Dasgupta A, Biddle DA, Wells A, Datta P. Positive and negative interference of the Chinese medicine Chan Su in serum digoxin measurement. Elimination of interference by using a monoclonal chemiluminescent digoxin assay or monitoring free digoxin concentration. Am J Clin Pathol 2000;114:174-9.
20. Datta P, Dasgupta A. Bidirectional (positive/negative) interference in a digoxin immunoassay: importance of antibody specificity. Ther Drug Monit 1998;20:352-7.
21. Rej R, Proficiency testing, matrix effects, and method evaluation [Editorial]. Clin Chem 1994;40:345-6.
22. Fishman J, Boyar RM, Hellman L. Influence of body weight on estradiol metabolism in young women. J Clin Endocrinol Metab 1975;41:989-91.
23. Thienpont LM, De Leenheer AP. Efforts by industry toward standardization of serum estradiol-17β measurements. Clin Chem 1998;44:671-4.
24. Siekmann L. Determination of oestradiol-17β in human serum by isotope dilution-mass spectrometry. Definitive methods in clinical chemistry, II. J Clin Chem Clin Biochem 1984;22:551-7.
25. Thienpont LM, Verhaeghe PG, Van Brussel KA, and De Leenheer AP. Estradiol-17β quantified in serum by isotope dilution-gas chromatography-mass spectrometry: reversed-phase C18 high-performance liquid chromatography compared with immuno-affinity chromatography for sample pretreatment. Clin Chem 1988;34:2066-9.
26. Dehennin L. Estradiol-17β determined in plasma by gas chromatography-mass spectrometry with selected ion monitoring of mixed silyl ether-perfluoroacyl ester derivatives and use of various stable-isotope-labeled internal standards. Clin Chem 1989;35:532-6.
27. Gaskell SJ, Brownsey BG. Immunoadsorption to improve gas chromatography/high-resolution mass spectrometry of estradiol17β in plasma. Clin Chem 1983;29:677-80.
28. Wu H, Ramsay C, Ozaeta P, Liu L, Aboleneen H. Serum estradiol quantified by isotope dilution-gas chromatography/mass spectrometry. Clin Chem 2002;48:364-6.
29. Wolthers BG, Kraan GP. Clinical applications of gas chromatography and gas chromatography-mass spectrometry of steroids. J Chromatogr A 1999;843:247-74.
30. Ravhon A, Lavery S, Trew G, Margara R, Winston R. Predictive value of serum estradiol levels for IVF pregnancy outcome after gonadotropin stimulation? Fertil Steril 1999;71:183-4.
31. Phophong P, Ranieri DM, Khadum I, Meo F, Serhal P. Basal 17β-estradiol did not correlate with ovarian response and in vitro fertilization treatment outcome. Fertil Steril 2000;74:1133-6.
32. Check JH. Low and high responders - at what levels of serum estradiol do things start to get fuzzy? Fertil Steril 1999;71:582-3.